Skip to main content
. 2018 May 4;19(5):1369. doi: 10.3390/ijms19051369

Figure 3.

Figure 3

Figure 3

(A) Images of immunofluorescent staining of FREM2: nuclei (left); FREM2 staining with anti-FREM2 antibodies (middle); merged presentation with original staining (right): nuclei (blue); FREM2 (red). White arrows indicate staining of FREM2 in cell membranes; (B) Images of immunofluorescent staining of SPRY1: nuclei (left); SPRY1 staining with anti-SPRY1 antibodies (middle); merged presentation with original staining (right): nuclei (blue); SPRY1 (red). White arrows indicate staining of SPRY1 in cell membranes.